These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 3016976)

  • 41. Comparison of bovine herpesvirus 1 vaccines for rapid induction of immunity.
    Roth JA; Carter DP
    Vet Ther; 2000; 1(4):220-8. PubMed ID: 19757568
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunopotentiation of bovine respiratory disease virus vaccines by interleukin-1 beta and interleukin-2.
    Reddy DN; Reddy PG; Xue W; Minocha HC; Daley MJ; Blecha F
    Vet Immunol Immunopathol; 1993 Jun; 37(1):25-38. PubMed ID: 8393601
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A study of the effectiveness of a needle-free injection device compared with a needle and syringe used to vaccinate calves against bovine viral diarrhea and infectious bovine rhinotracheitis viruses.
    Rey MR; Undi M; Rodriguez-Lecompte JC; Joseph T; Morrison J; Yitbarek A; Wittenberg K; Tremblay R; Crow GH; Ominski KH
    Vet J; 2013 Oct; 198(1):235-8. PubMed ID: 24011475
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early immunity induced by a live gE-negative bovine herpesvirus 1 marker vaccine.
    Kaashoek MJ; van Oirschot JT
    Vet Microbiol; 1996 Nov; 53(1-2):191-7. PubMed ID: 9011011
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of a modified live virus type-1a bovine viral diarrhea virus vaccine (Singer strain) against a type-2 (strain 890) challenge.
    Fairbanks K; Schnackel J; Chase CC
    Vet Ther; 2003; 4(1):24-34. PubMed ID: 12756633
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modification of active immunization with live bovine herpesvirus 1 vaccine by passive viral antibody.
    Patel JR; Shilleto RW
    Vaccine; 2005 Jul; 23(31):4023-8. PubMed ID: 15916839
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Production of cattle immunotolerant to bovine viral diarrhea virus.
    McClurkin AW; Littledike ET; Cutlip RC; Frank GH; Coria MF; Bolin SR
    Can J Comp Med; 1984 Apr; 48(2):156-61. PubMed ID: 6326980
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immune responsiveness in cattle fatally affected by bovine virus diarrhea-mucosal disease.
    Steck F; Lazary S; Fey H; Wandeler A; Huggler C; Oppliger G; Baumberger H; Kaderli R; Martig J
    Zentralbl Veterinarmed B; 1980; 27(6):429-45. PubMed ID: 6258359
    [No Abstract]   [Full Text] [Related]  

  • 49. Efficacy of intranasal vaccination with a multivalent vaccine containing temperature-sensitive modified-live bovine herpesvirus type 1 for protection of seronegative and seropositive calves against respiratory disease.
    Mahan SM; Sobecki B; Johnson J; Oien NL; Meinert TR; Verhelle S; Mattern SJ; Bowersock TL; Leyh RD
    J Am Vet Med Assoc; 2016 Jun; 248(11):1280-6. PubMed ID: 27172345
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Seroprevalence of infectious bovine rhinotracheitis and bovine viral diarrhea virus type 1 and type 2 in non-vaccinated cattle herds in the Pacific Region of Central Costa Rica.
    Raizman EA; Pogranichniy R; Negron M; Schnur M; Tobar-Lopez DE
    Trop Anim Health Prod; 2011 Apr; 43(4):773-8. PubMed ID: 21128116
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of humoral immune responses in dairy heifers vaccinated with 3 different commercial vaccines against bovine viral diarrhea virus and bovine herpesvirus-1.
    DesCôteaux L; Cécyre D; Elsener J; Beauchamp G
    Can Vet J; 2003 Oct; 44(10):816-21. PubMed ID: 14601677
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A bovine virus diarrhea calfhood vaccination trial in a persistently infected herd: effects on titres, health and growth.
    Ernst PB; Butler DG
    Can J Comp Med; 1983 Apr; 47(2):118-23. PubMed ID: 6309345
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serological study of a modified-live virus IBR vaccine given to feedlot calves after arrival.
    van Donkersgoed J; Klassen P
    Can Vet J; 1995 Jun; 36(6):394. PubMed ID: 7648547
    [No Abstract]   [Full Text] [Related]  

  • 54. Immune response to infectious bovine rhinotracheitis virus (IBRV) following natural infection or vaccination by intranasally or parenterally administered vaccines.
    Todd JD
    Dev Biol Stand; 1975; 28():526-9. PubMed ID: 165128
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immune responses to non-structural protein 3 (NS3) of bovine viral diarrhoea virus (BVDV) in NS3 DNA vaccinated and naturally infected cattle.
    Young NJ; Thomas CJ; Thompson I; Collins ME; Brownlie J
    Prev Vet Med; 2005 Nov; 72(1-2):115-20; discussion 215-9. PubMed ID: 16169103
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence of antibodies to bovid herpesvirus 1 (IBR-IPV), bovine virus diarrhoea, bovine respiratory syncytial parainfluenza 3, adeno A and adeno B viruses in indigenous and imported Moroccan cattle.
    Mahin L; Wellemans G; Shimi A
    Ann Rech Vet; 1985; 16(3):279-83. PubMed ID: 2998260
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Early immunity induced by a glycoprotein E-negative vaccine for infectious bovine rhinotracheitis.
    Makoschey B; Keil GM
    Vet Rec; 2000 Aug; 147(7):189-91. PubMed ID: 10985462
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protection from parainfluenza-3 virus and persistence of infectious bovine rhinotracheitis virus in sheep vaccinated with a modified live IBR-PI-3 vaccine.
    Lehmkuhl HD; Cutlip RC
    Can J Comp Med; 1985 Jan; 49(1):58-62. PubMed ID: 2985216
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of a combination viral vaccine for protection of cattle against experimental infection with field isolates of bovine herpesvirus-1.
    Ellis JA; Gow SP; Goji N; Jones C; Workman A; Henderson G; Rhodes C; Alaniz G; Meinert TR; Tucker CM
    J Am Vet Med Assoc; 2009 Sep; 235(5):563-72. PubMed ID: 19719449
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antibody responses by cattle after vaccination with commercial viral vaccines containing bovine herpesvirus-1, bovine viral diarrhea virus, parainfluenza-3 virus, and bovine respiratory syncytial virus immunogens and subsequent revaccination at day 140.
    Fulton RW; Confer AW; Burge LJ; Perino LJ; d'Offay JM; Payton ME; Mock RE
    Vaccine; 1995; 13(8):725-33. PubMed ID: 7483787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.